mitoxantrone has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Preet, G | 3 |
| Oluwabusola, ET | 3 |
| Milne, BF | 3 |
| Ebel, R | 3 |
| Jaspars, M | 3 |
| Reder, AT | 1 |
| Centonze, D | 1 |
| Naylor, ML | 1 |
| Nagpal, A | 1 |
| Rajbhandari, R | 1 |
| Altincatal, A | 1 |
| Kim, M | 1 |
| Berdofe, A | 1 |
| Radhakrishnan, M | 1 |
| Jung, E | 1 |
| Sandrock, AW | 1 |
| Smirnakis, K | 1 |
| Popescu, C | 1 |
| de Moor, C | 1 |
2 other studies available for mitoxantrone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Topics: Animals; COVID-19; Drug Repositioning; Humans; Mitoxantrone; Molecular Docking Simulation; Monkeypox | 2022 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cl | 2021 |